THOMPSON KIMBERLY KRAIG (CEO, CFO) reported 1 transaction at KRAIG BIOCRAFT LABORATORIES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/10/2025ACC: 0001641172-25-003638
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
+27.50K
Net shares
Net buyer
$2.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
27.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+27.50K
Price / share
$0.09
Trade value
$2.49K
% of position
0.0%
3/31/2025
201.65M→201.68M
Total
Net shares
+27.50K
Net value
$2.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | W · W | +27.50K | $0.09 | $2.49K | 0.0% | 201.65M | 201.68M |
| Total | +27.50K | $2.49K | ||||||
Derivative Transactions0
No derivative transactions reported